공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 비침습 미용 치료 시장 : 시장 규모, 점유율 및 동향 분석, 부문별 예측(시술별(피부 재생, 주사제), 지역별)

Non-invasive Aesthetic Treatment Market Size, Share & Trends Analysis Report By Procedure (Skin Rejuvenation, Injectables), By Region, And Segment Forecasts, 2021 - 2028

리서치사 Grand View Research, Inc.
발행일 2020년 12월 상품 코드 986179
페이지 정보 영문 110 Pages
가격
US $ 5,950 ₩ 6,902,000 Unprintable PDF (Single User License)
US $ 6,950 ₩ 8,062,000 Printable PDF (5-User License)
US $ 8,950 ₩ 10,382,000 Printable PDF (Enterprise License)


세계의 비침습 미용 치료 시장 : 시장 규모, 점유율 및 동향 분석, 부문별 예측(시술별(피부 재생, 주사제), 지역별) Non-invasive Aesthetic Treatment Market Size, Share & Trends Analysis Report By Procedure (Skin Rejuvenation, Injectables), By Region, And Segment Forecasts, 2021 - 2028
발행일 : 2020년 12월 페이지 정보 : 영문 110 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 비침습 미용 치료(에스테틱 트리트먼트) 시장 규모는 향후 13.9%의 연평균 복합 성장률(CAGR)로 확대되어 2028년까지 185억 달러에 이를 것으로 추정됩니다. 비침습식 이 침습식보다 통증이 적고, 단기간에 결과가 나오며, 저비용이기도 하기 때문에 외과적 치료에서 비침습 치료로 전환하는 동향이 확대되고 있습니다.

세계의 비침습 미용 치료(Non-invasive Aesthetic Treatment) 시장을 분석했으며, 시장의 기본 구조, 주요 시장 성장 촉진요인 및 억제요인 시술별·지역별 시장 동향 전망(향후 8년간), 주요 기업 개요와 전략 전개 상황 등의 정보를 정리하여 전해드립니다.

목차

제1장 분석 방법과 범위

제2장 개요

제3장 비침습 미용 치료 시장 : 변수, 동향, 범위

  • 보급률 및 성장률 전망 : 매핑
  • 시장 역학
  • 비침습 미용 치료 시장 : 시장 분석 툴

제4장 비침습 미용 치료 시장 분석 : 시술별

  • 정의와 범위
  • 시장 점유율 분석 : 시술별(최신 수치, 예측)
  • 비침습 미용 치료 시장 : 시술별(실적, 예측)
  • 시장 규모 예측과 동향 분석 : 시술별(실적, 예측)
    • 주사제
    • 피부 재생
    • 기타

제5장 비침습 미용 치료 시장 분석 : 지역별

  • 정의와 범위
  • 시장 점유율 분석 : 지역별(최신 수치, 예측)
  • 시장 대시보드 : 지역별
  • 시장 규모 예측과 동향 분석 : 지역별(실적, 예측)
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 덴마크
    • 스웨덴
    • 노르웨이
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 태국
    • 한국
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
  • 중동 및 아프리카
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트(UAE)

제6장 비침습 미용 치료 시장 : 경쟁 분석

  • 주요 기업 분류(혁신 기업, 선구 기업, 신규 기업)
  • 벤더 구도
    • 주요 유통업체 및 채널 파트너 리스트
  • 분석 대상 주요 기업
    • Hologic, Inc.
    • Allergan, Inc.
    • Galderma S.A.
    • Alma Lasers
    • Syneron Candela
    • Johnson & Johnson
    • Merz Pharma
    • Lumenis
    • Solta Medical
    • Cutera, Inc.
    • Revance Therapeutics Inc.
LSH 21.02.10

List of Tables

  • Table 1 Global Non-invasive Aesthetic Treatment Market, By Region, 2016 - 2028 (USD Million)
  • Table 2 Global Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 3 North America Non-invasive Aesthetic Treatment Market, By Country, 2016 - 2028 (USD Million)
  • Table 4 North America Non-invasive Aesthetic Treatment Market, By Procedure2016 - 2028 (USD Million)
  • Table 5 U.S. Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 6 Canada Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 7 Europe Non-invasive Aesthetic Treatment Market, By Country, 2016 - 2028 (USD Million)
  • Table 8 Europe Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 9 U.K. Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 10 Germany Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 11 France Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 12 Italy Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 13 Spain Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 14 Denmark Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 15 Sweden Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 16 Norway Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 17 Asia Pacific Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 18 Japan Non-invasive Aesthetic Treatment Market, By Procedure2016 - 2028 (USD Million)
  • Table 19 China Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 20 India Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 21 Thailand Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 22 South Korea Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 23 Latin America Non-invasive Aesthetic Treatment Market, By Country, 2016 - 2028 (USD Million)
  • Table 24 Latin America Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 25 Brazil Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 26 Mexico Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 27 Argentina Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 28 Colombia Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 29 Middle East & Africa Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 30 South Africa Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 31 Saudi Arabia Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)
  • Table 32 UAE Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028 (USD Million)

List of Figures

  • Figure 1 Market research process
  • Figure 2 Information procurement
  • Figure 3 Primary research pattern
  • Figure 4 Market research approaches
  • Figure 5 Value chain-based sizing & forecasting
  • Figure 6 QFD modelling for market share assessment
  • Figure 7 Market formulation & validation
  • Figure 8 Non-invasive aesthetic treatment market segmentation
  • Figure 9 Market driver relevance analysis (Current & future impact)
  • Figure 10 Market restraint relevance analysis (Current & future impact)
  • Figure 11 Market challenge relevance analysis (Current & future impact)
  • Figure 12 Penetration & growth prospect mapping
  • Figure 13 SWOT analysis, by factor (political & legal, economic and technological)
  • Figure 14 Porter's five forces analysis
  • Figure 15 Market penetration vs growth prospect mapping
  • Figure 16 Non-invasive aesthetic treatment market: procedure movement analysis
  • Figure 17 Regional marketplace: Key takeaways
  • Figure 18 Regional outlook, 2018 & 2020
  • Figure 19 North America Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 20 The U.S. Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 21 Canada Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million))
  • Figure 22 Europe Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 23 The U.K. Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 24 Germany Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 25 Italy Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 26 Spain Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 27 Sweden Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 28 Denmark Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 29 Norway Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 30 France Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 31 Asia Pacific Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 32 Japan Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 33 China Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 34 India Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 35 Thailand Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 36 South Korea Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 37 Latin America Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 38 Brazil Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 39 Mexico Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 40 Argentina Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 41 Colombia Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 42 MEA Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 43 South Africa Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 44 Saudi Arabia Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)
  • Figure 45 UAE Non-invasive aesthetic treatment market, 2016 - 2028 (USD Million)

Non-invasive Aesthetic Treatment Market Growth & Trends:

The global non-invasive aesthetic treatment market size is expected to reach USD 18.5 billion by 2028, according to a new report by Grand View Research, Inc., registering a CAGR of 13.9% over the forecast period. Non-invasive aesthetic treatment offer benefits, such as less pain, instant results, and low cost, over invasive treatment. Non-invasive aesthetic treatment does not serve permanent results; however, it temporarily enhances facial appearance and aids in delaying the signs of aging.

According to a report published by the International Society of Aesthetic Plastic Surgery (ISAPS), between 2017 and 2018, there was an 11.7% increase in nonsurgical procedures and a decrease of 0.6% in surgical procedures. This highlights the high growth prospects for the market in the coming years. Non-invasive aesthetic treatment includes procedures, such as skin rejuvenation and injectables.

Popular injectable procedures include botulinum toxin, hyaluronic acid, and polymer filler. According to the American Society of Plastic Surgeons (ASPS), in 2019, botulinum toxin was among the top 5 minimally invasive procedures carried out in the U.S. Asia Pacific is expected to be the fastest-growing regional market over the forecast period due to the rapidly growing population in countries, such as India and China.

Non-invasive Aesthetic Treatment Market Report Highlights:

  • Injectable procedure is projected to be the leading procedure segment over the forecast period
  • Among various injectable procedures, botulinum toxin is one of the most widely used minimally invasive treatment
  • North America was the dominant regional market in 2020 accounting for a share of around 37% due to the availability and adoption of advanced treatment options in this region
  • Asia Pacific is projected to register the fastest CAGR over the forecast period on account of the rising target population in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market segmentation & scope
  • 1.2. Information procurement
    • 1.2.1. Purchased database
    • 1.2.2. GVR's internal database
    • 1.2.3. Secondary sources & third-party perspectives
    • 1.2.4. Primary research
  • 1.3. Information analysis
    • 1.3.1. Data analysis models
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing

Chapter 2. Executive Summary

Chapter 3. Non-invasive Aesthetic Treatment Market Variables, Trends & Scope

  • 3.1. Penetration & Growth Prospect Mapping
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing beauty consciousness among consumers
      • 3.2.1.2. Growing geriatric population
    • 3.2.2. Market Restraint Analysis
  • 3.3. Non-invasive Aesthetic Treatment: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat from new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Social Landscape
      • 3.3.2.3. Technology Landscape
      • 3.3.2.4. Legal Landscape

Chapter 4. Non-invasive Aesthetic Treatment Market: Segment Analysis, By -Procedure, 2016 - 2018 (USD Million)

  • 4.1. Definitions & Scope
  • 4.2. Procedure market share analysis, 2020 & 2028
  • 4.3. Global Non-invasive Aesthetic Treatment Market, By Procedure, 2016 - 2028
  • 4.4. Market Size & Forecasts and Trend Analyses, 2016 - 2028 for the following
    • 4.4.1. Injectables
    • 4.4.2. Skin Rejuvenation
    • 4.4.3. Others

Chapter 5. Non-invasive Aesthetic Treatment Market: Regional Market Analysis, By Region, 2016 - 2028 (USD Million)

  • 5.1. Definitions & Scope
  • 5.2. Regional market share analysis, 2020 & 2028
  • 5.3. Regional Market Dashboard
  • 5.4. Market Size, & Forecasts, and Trend Analysis, 2020 to 2028:
  • 5.5. North America
    • 5.5.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 5.5.2. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
    • 5.5.3. The U.S.
      • 5.5.3.1. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
    • 5.5.4. Canada
      • 5.5.4.1. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
  • 5.6. Europe
    • 5.6.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 5.6.2. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
    • 5.6.3. Germany
      • 5.6.3.1. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
    • 5.6.4. The U.K.
      • 5.6.4.1. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
    • 5.6.5. France
      • 5.6.5.1. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
    • 5.6.6. Italy
      • 5.6.6.1. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
    • 5.6.7. Spain
      • 5.6.7.1. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
    • 5.6.8. Denmark
      • 5.6.8.1. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
    • 5.6.9. Sweden
      • 5.6.9.1. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
    • 5.6.10. Norway
      • 5.6.10.1. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
  • 5.7. Asia Pacific
    • 5.7.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 5.7.2. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
    • 5.7.3. China
      • 5.7.3.1. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
    • 5.7.4. Japan
      • 5.7.4.1. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
    • 5.7.5. India
      • 5.7.5.1. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
    • 5.7.6. Thailand
      • 5.7.6.1. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
    • 5.7.7. South Korea
      • 5.7.7.1. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
  • 5.8. Latin America
    • 5.8.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 5.8.2. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
    • 5.8.3. Brazil
      • 5.8.3.1. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
    • 5.8.4. Mexico
      • 5.8.4.1. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
    • 5.8.5. Argentina
      • 5.8.5.1. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
    • 5.8.6. Colombia
      • 5.8.6.1. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
  • 5.9. Middle East and Africa
    • 5.9.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 5.9.2. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
    • 5.9.3. South Africa
      • 5.9.3.1. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
    • 5.9.4. Saudi Arabia
      • 5.9.4.1. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)
    • 5.9.5. UAE
      • 5.9.5.1. Market estimates and forecast, by procedure, 2016 - 2028 (USD Million)

Chapter 6. Non-invasive Aesthetic Treatment Market - Competitive Analysis

  • 6.1. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 6.2. Vendor Landscape
    • 6.2.1. List of key distributors and channel partners
  • 6.3. Key companies profiled
    • 6.3.1. Hologic, Inc.
      • 6.3.1.1. Company Overview
      • 6.3.1.2. Financial Performance
      • 6.3.1.3. Product Benchmarking
      • 6.3.1.4. Strategic Initiatives
    • 6.3.2. Allergan, Inc.
      • 6.3.2.1. Company Overview
      • 6.3.2.2. Financial Performance
      • 6.3.2.3. Product Benchmarking
      • 6.3.2.4. Strategic Initiatives
    • 6.3.3. Galderma S.A.
      • 6.3.3.1. Company Overview
      • 6.3.3.2. Financial Performance
      • 6.3.3.3. Product Benchmarking
      • 6.3.3.4. Strategic Initiatives
    • 6.3.4. Alma Lasers
      • 6.3.4.1. Company Overview
      • 6.3.4.2. Financial Performance
      • 6.3.4.3. Product Benchmarking
      • 6.3.4.4. Strategic Initiatives
    • 6.3.5. Syneron Candela
      • 6.3.5.1. Company Overview
      • 6.3.5.2. Financial Performance
      • 6.3.5.3. Product Benchmarking
      • 6.3.5.4. Strategic Initiatives
    • 6.3.6. Johnson & Johnson
      • 6.3.6.1. Company Overview
      • 6.3.6.2. Financial Performance
      • 6.3.6.3. Product Benchmarking
      • 6.3.6.4. Strategic Initiatives
    • 6.3.7. Merz Pharma
      • 6.3.7.1. Company Overview
      • 6.3.7.2. Financial Performance
      • 6.3.7.3. Product Benchmarking
      • 6.3.7.4. Strategic Initiatives
    • 6.3.8. Lumenis
      • 6.3.8.1. Company Overview
      • 6.3.8.2. Financial Performance
      • 6.3.8.3. Product Benchmarking
      • 6.3.8.4. Strategic Initiatives
    • 6.3.9. Solta Medical
      • 6.3.9.1. Company Overview
      • 6.3.9.2. Financial Performance
      • 6.3.9.3. Product Benchmarking
      • 6.3.9.4. Strategic Initiatives
    • 6.3.10. Cutera, Inc.
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives.
    • 6.3.11. Revance Therapeutics Inc.
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives.
Back to Top
전화 문의
F A Q